COMP <GO>
EMN vs NEM // NET PROFIT MARGIN
Eastman Chemical Company (NYSE) VS. Newmont Corporation (NYSE) • 15-METRIC TALLY: EMN 4
— NEM 11
▲ NET PROFIT MARGIN LEADER: NEM
LAST: $66.53 (-2.06%) • MKT CAP: $7.77B
net-margins
5.40%
LAST: $106.61 (-4.64%) • MKT CAP: $116.18B
net-margins
31.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EMN VS. NEM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EMN | NEM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 21.10% | 41.00% | -19.90 | NEM | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.80% | 21.80% | -17.00 | NEM | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.9x | 11.9x | -1.00 | EMN | /valuation <GO> |
| Free Cash Flow Yield | 5.46% | 8.02% | -2.56 | NEM | /fcf-yield <GO> |
| Operating Margin | 6.60% | 38.10% | -31.50 | NEM | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 5.40% | 31.30% | -25.90 | NEM | /net-margins <GO> |
| Revenue Growth (YoY) | -6.70% | 21.30% | -28.00 | NEM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 4.90% | 0.95% | +3.95 | EMN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.28 | 4.16 | -1.88 | NEM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 9/9 | -3.00 | NEM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 7.00% | +0.10 | NEM | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.1 | 36.1 | +19.02 | EMN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.06 | 1.04 | +0.02 | EMN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.3x | 13.8x | +1.50 | NEM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.77B | $116.18B | -$108.41B | NEM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EMN REV | NEM REV | EMN GROSS % | NEM GROSS % | EMN FCF | NEM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.75B | $22.67B | 21.1% | 44.0% | $424.0M | $9.31B |
| FY 2024 | $9.38B | $18.68B | 24.4% | 44.0% | $688.0M | $5.52B |
| FY 2023 | $9.21B | $11.81B | 44.0% | 44.0% | $959.5M | $2.23B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EMN // BETA 1.06
NEM // BETA 1.04